LMP1 has been shown to induce many of the features of the aberrant transcriptional programme characteristic of the tumour cells of cHL, including the down-regulation of BCR signalling components, and the increased expression of anti-apoptotic genes such as BCL2 and BFL-1 [20, 81]. Here, BCR is linked to neoplasm.